5-Bromo-2-[[(tert-butyldimethylsilyl)oxy]methyl]pyridine - CAS 88139-92-8
Catalog: |
BB038748 |
Product Name: |
5-Bromo-2-[[(tert-butyldimethylsilyl)oxy]methyl]pyridine |
CAS: |
88139-92-8 |
Synonyms: |
(5-bromo-2-pyridinyl)methoxy-tert-butyl-dimethylsilane; (5-bromopyridin-2-yl)methoxy-tert-butyl-dimethylsilane |
IUPAC Name: | (5-bromopyridin-2-yl)methoxy-tert-butyl-dimethylsilane |
Description: | 5-Bromo-2-[[(tert-butyldimethylsilyl)oxy]methyl]pyridine (CAS# 88139-92-8 ) is a useful research chemical. |
Molecular Weight: | 302.28 |
Molecular Formula: | C12H20BrNOSi |
Canonical SMILES: | CC(C)(C)[Si](C)(C)OCC1=NC=C(C=C1)Br |
InChI: | InChI=1S/C12H20BrNOSi/c1-12(2,3)16(4,5)15-9-11-7-6-10(13)8-14-11/h6-8H,9H2,1-5H3 |
InChI Key: | RQWUXKJRTKREAL-UHFFFAOYSA-N |
LogP: | 4.36590 |
Publication Number | Title | Priority Date |
CN-112979655-A | Triazolopyridazine derivative, preparation method, pharmaceutical composition and application thereof | 20191216 |
WO-2021121294-A1 | Triazolopyridazine derivative, preparation method therefor, pharmaceutical composition thereof, and use thereof | 20191216 |
WO-2020243459-A1 | Thiadiazolyl derivatives as dna polymerase theta inhibitors | 20190531 |
US-10519152-B2 | Compounds and their use in treating cancer | 20171221 |
US-2019194190-A1 | Compounds and Their Use in Treating Cancer | 20171221 |
Complexity: | 228 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 301.04975 |
Formal Charge: | 0 |
Heavy Atom Count: | 16 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 301.04975 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 22.1 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Pyridines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS